PayPay (NASDAQ:PAYP) Earns Overweight Rating from Analysts at Cantor Fitzgerald

Cantor Fitzgerald started coverage on shares of PayPay (NASDAQ:PAYPFree Report) in a research report report published on Monday, MarketBeat reports. The firm issued an overweight rating and a $25.00 price objective on the fintech company’s stock.

Several other research firms also recently weighed in on PAYP. Citigroup started coverage on shares of PayPay in a research note on Monday. They issued a “neutral” rating and a $23.00 price target for the company. Bank of America started coverage on shares of PayPay in a research report on Monday. They set a “buy” rating and a $26.00 target price for the company. Mizuho started coverage on shares of PayPay in a research report on Monday. They set an “outperform” rating and a $26.00 target price for the company. Morgan Stanley started coverage on shares of PayPay in a research report on Monday. They set an “equal weight” rating and a $24.00 target price for the company. Finally, Wall Street Zen raised shares of PayPay to a “hold” rating in a research report on Saturday, March 21st. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $25.73.

View Our Latest Stock Report on PayPay

PayPay Stock Performance

PAYP stock opened at $20.36 on Monday. PayPay has a 12-month low of $17.00 and a 12-month high of $24.89.

PayPay (NASDAQ:PAYPGet Free Report) last released its earnings results on Thursday, February 12th. The fintech company reported $0.18 earnings per share (EPS) for the quarter. The firm had revenue of $636.46 million during the quarter.

Key Stories Impacting PayPay

Here are the key news stories impacting PayPay this week:

  • Positive Sentiment: Goldman Sachs upgraded PayPay to “strong-buy” (and reported a buy view with a $29 price target, ~42% upside from the current price), boosting conviction among growth/fintech investors. Read More.
  • Positive Sentiment: JPMorgan initiated coverage with an “overweight” rating and a $25 price target (~23% upside), adding another blue‑chip endorsement that likely supports the rally. Read More.
  • Positive Sentiment: Investor’s Business Daily (IBD) upgraded PayPay’s rating for improved price strength — a technical recognition that can attract momentum and retail traders. Read More.
  • Positive Sentiment: Media/analysis coverage noted the share jump (articles explaining a ~5% intraday move), which can create follow‑on buying from momentum traders and algorithms. Read More.
  • Neutral Sentiment: A broad set of firms (Morgan Stanley, Deutsche Bank, Benchmark, Mizuho, Wolfe Research, Cantor Fitzgerald, Citi, Jefferies and others) initiated coverage on PAYP over the same 24‑hour period. New coverage increases analyst attention and liquidity, but the impact will hinge on each shop’s specific ratings and price targets (not all initiations were accompanied by detailed PTs in initial reports). Read More. Read More. Read More. Read More. Read More. Read More. Read More. Read More.

About PayPay

(Get Free Report)

As Japan’s leading financial technology company, we are dedicated to our goal of becoming a digital finance platform for all. We strive to empower the everyday lives of users and businesses by transforming their smartphones into a comprehensive, easy-to-use, and accessible financial platform that centralizes and simplifies numerous daily activities for ultimate convenience. Through a seamless ecosystem of payment, financial and everyday services, we have served as a game-changer in driving the shift to a cashless and digitally empowered economy.

Read More

Analyst Recommendations for PayPay (NASDAQ:PAYP)

Receive News & Ratings for PayPay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PayPay and related companies with MarketBeat.com's FREE daily email newsletter.